Nomura Holdings’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,666
Closed -$1.05M 1876
2025
Q4
$1.05M Buy
+15,666
New +$1.05M ﹤0.01% 1321
2025
Q1
Sell
-16,851
Closed -$806K 2003
2024
Q4
$806K Buy
+16,851
New +$864K ﹤0.01% 1580
2014
Q1
Sell
-19,272
Closed -$289K 2788
2013
Q4
$289K Buy
+19,272
New +$248K ﹤0.01% 1565
2013
Q3
Sell
-53,657
Closed -$427K 2437
2013
Q2
$427K Buy
+53,657
New +$342K ﹤0.01% 1418

Other funds holding HALO

Nomura Holdings's HALO Position: Q1 2026 in Review

Nomura Holdings sold out of Halozyme (HALO) in Q1 2026, closing a stake of 15,666 shares — an estimated $1.05M sold.

Nomura Holdings first reported a position in HALO in Q2 2013 and held it in 4 quarters. The position peaked at $1.05M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Nomura Holdings reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 15,666 Halozyme shares in Q1 2026, an estimated $1.05M.
  • Nomura Holdings first reported a position in Halozyme in Q2 2013 and held it in 4 quarters.
  • Nomura Holdings's Halozyme position peaked at $1.05M in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.